Related references
Note: Only part of the references are listed.FBXO6-mediated RNASET2 ubiquitination and degradation governs the development of ovarian cancer
Mei Ji et al.
CELL DEATH & DISEASE (2021)
FBXO16-mediated hnRNPL ubiquitination and degradation plays a tumor suppressor role in ovarian cancer
Mei Ji et al.
CELL DEATH & DISEASE (2021)
Emerging Roles of USP18: From Biology to Pathophysiology
Ji An Kang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
USP18 is crucial for IFN-γ-mediated inhibition of B16 melanoma tumorigenesis and antitumor immunity
Bangxing Hong et al.
MOLECULAR CANCER (2014)
USP18-Based Negative Feedback Control Is Induced by Type I and Type III Interferons and Specifically Inactivates Interferon α Response
Veronique Francois-Newton et al.
PLOS ONE (2011)
Angiogenesis inhibitors for the treatment of ovarian cancer
Kezia Gaitskell et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2011)
Identification of USP18 as an Important Regulator of the Susceptibility to IFN-α and Drug-Induced Apoptosis
Harish Potu et al.
CANCER RESEARCH (2010)
STAT proteins:: From normal control of cellular events to tumorigenesis
V Calò et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2003)
Protein ISGylation modulates the JAK-STAT signaling pathway
OA Malakhova et al.
GENES & DEVELOPMENT (2003)
UBP43 (USP18) specifically removes ISG15 from conjugated proteins
MP Malakhov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Cloning and characterization of a novel human ubiquitin-specific protease, a homologue of murine UBP43 (Usp18)
H Schwer et al.
GENOMICS (2000)